Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Magnetic Resonance Imaging Evidence for Human Immunodeficiency Virus Effects on Central Auditory Processing: A Review.

Zhan Y, Buckey JC, Fellows AM, Shi Y.

J AIDS Clin Res. 2017 Jul;8(7). pii: 708. doi: 10.4172/2155-6113.1000708. Epub 2017 Jul 11.

2.

Mechanisms of Cognitive Aging in the HIV-Positive Adult.

Kamkwalala A, Newhouse P.

Curr Behav Neurosci Rep. 2017 Sep;4(3):188-197. doi: 10.1007/s40473-017-0122-9. Epub 2017 Jul 19.

PMID:
28840088
3.

Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Patients Older Than 60 Years.

Clifford KM, Samboju V, Cobigo Y, Milanini B, Marx GA, Hellmuth JM, Rosen HJ, Kramer JH, Allen IE, Valcour VG.

J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):289-297. doi: 10.1097/QAI.0000000000001489.

PMID:
28650401
4.

HIV, Tat and dopamine transmission.

Gaskill PJ, Miller DR, Gamble-George J, Yano H, Khoshbouei H.

Neurobiol Dis. 2017 Sep;105:51-73. doi: 10.1016/j.nbd.2017.04.015. Epub 2017 Apr 27. Review.

PMID:
28457951
5.

Deformed Subcortical Structures Are Related to Past HIV Disease Severity in Youth With Perinatally Acquired HIV Infection.

Lewis-de Los Angeles CP, Alpert KI, Williams PL, Malee K, Huo Y, Csernansky JG, Yogev R, Van Dyke RB, Sowell ER, Wang L; Pediatric HIV/AIDS Cohort Study (PHACS).

J Pediatric Infect Dis Soc. 2016 Dec;5(suppl 1):S6-S14.

PMID:
27856671
6.

Development of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection.

Atluri VS, Jayant RD, Pilakka-Kanthikeel S, Garcia G, Samikkannu T, Yndart A, Kaushik A, Nair M.

Int J Nanomedicine. 2016 Aug 31;11:4287-98. doi: 10.2147/IJN.S108329. eCollection 2016.

7.

Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era.

Guha A, Brier MR, Ortega M, Westerhaus E, Nelson B, Ances BM.

J Acquir Immune Defic Syndr. 2016 Dec 1;73(4):374-383.

PMID:
27454251
8.

Effects of HIV/TAT protein expression and chronic selegiline treatment on spatial memory, reversal learning and neurotransmitter levels in mice.

Kesby JP, Markou A, Semenova S; TMARC Group.

Behav Brain Res. 2016 Sep 15;311:131-140. doi: 10.1016/j.bbr.2016.05.034. Epub 2016 May 17.

9.

Putamen volume and its clinical and neurological correlates in primary HIV infection.

Wright PW, Pyakurel A, Vaida FF, Price RW, Lee E, Peterson J, Fuchs D, Zetterberg H, Robertson KR, Walter R, Meyerhoff DJ, Spudich SS, Ances BM.

AIDS. 2016 Jul 17;30(11):1789-94. doi: 10.1097/QAD.0000000000001103.

10.

Oxidative mitochondrial DNA damage in peripheral blood mononuclear cells is associated with reduced volumes of hippocampus and subcortical gray matter in chronically HIV-infected patients.

Kallianpur KJ, Gerschenson M, Mitchell BI, LiButti DE, Umaki TM, Ndhlovu LC, Nakamoto BK, Chow DC, Shikuma CM.

Mitochondrion. 2016 May;28:8-15. doi: 10.1016/j.mito.2016.02.006. Epub 2016 Feb 23.

11.

Synaptic Plasticity and Neurological Disorders in Neurotropic Viral Infections.

Atluri VS, Hidalgo M, Samikkannu T, Kurapati KR, Nair M.

Neural Plast. 2015;2015:138979. doi: 10.1155/2015/138979. Epub 2015 Nov 16. Review.

12.

Mapping abnormal subcortical brain morphometry in an elderly HIV+ cohort.

Wade BS, Valcour VG, Wendelken-Riegelhaupt L, Esmaeili-Firidouni P, Joshi SH, Gutman BA, Thompson PM.

Neuroimage Clin. 2015 Oct 8;9:564-73. doi: 10.1016/j.nicl.2015.10.006. eCollection 2015.

13.

Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's Disease.

DeVaughn S, Müller-Oehring EM, Markey B, Brontë-Stewart HM, Schulte T.

Neuropsychol Rev. 2015 Dec;25(4):424-38. doi: 10.1007/s11065-015-9305-x. Epub 2015 Nov 17. Review.

14.

Impact of cocaine abuse on HIV pathogenesis.

Dash S, Balasubramaniam M, Villalta F, Dash C, Pandhare J.

Front Microbiol. 2015 Oct 20;6:1111. doi: 10.3389/fmicb.2015.01111. eCollection 2015. Review.

15.

Reward, attention, and HIV-related risk in HIV+ individuals.

Anderson BA, Kronemer SI, Rilee JJ, Sacktor N, Marvel CL.

Neurobiol Dis. 2016 Aug;92(Pt B):157-65. doi: 10.1016/j.nbd.2015.10.018. Epub 2015 Oct 17.

16.

Age exacerbates HIV-associated white matter abnormalities.

Seider TR, Gongvatana A, Woods AJ, Chen H, Porges EC, Cummings T, Correia S, Tashima K, Cohen RA.

J Neurovirol. 2016 Apr;22(2):201-12. doi: 10.1007/s13365-015-0386-3. Epub 2015 Oct 7.

17.

Effects of HIV and childhood trauma on brain morphometry and neurocognitive function.

Spies G, Ahmed-Leitao F, Fennema-Notestine C, Cherner M, Seedat S.

J Neurovirol. 2016 Apr;22(2):149-58. doi: 10.1007/s13365-015-0379-2. Epub 2015 Sep 30.

18.

HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease?

Cohen RA, Seider TR, Navia B.

Alzheimers Res Ther. 2015 Apr 6;7(1):37. doi: 10.1186/s13195-015-0123-4. eCollection 2015.

19.

Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice.

Kesby JP, Heaton RK, Young JW, Umlauf A, Woods SP, Letendre SL, Markou A, Grant I, Semenova S.

Neuropsychopharmacology. 2015 Jul;40(8):1899-909. doi: 10.1038/npp.2015.39. Epub 2015 Feb 5.

20.

HIV-1 proteins, Tat and gp120, target the developing dopamine system.

Fitting S, Booze RM, Mactutus CF.

Curr HIV Res. 2015;13(1):21-42. Review.

Supplemental Content

Support Center